HODGKIN'S LYMPHOMA
Clinical trials for HODGKIN'S LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HODGKIN'S LYMPHOMA trials appear
Sign up with your email to follow new studies for HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged immune cells take on Hard-to-Treat lymphoma
Disease control OngoingThis early-phase study tests a new way to fight Hodgkin and non-Hodgkin lymphoma that has returned or not responded to standard treatment. Researchers take a patient's own immune cells (T cells), add a special receptor that targets the CD30 protein on lymphoma cells, and also tra…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for rare cancers: drug trial targets hard-to-treat tumors
Disease control TerminatedThis study tests a drug called XmAb20717 in 140 adults with advanced rare cancers, including mesothelioma, cervical cancer, and Hodgkin's lymphoma. The goal is to see if the drug can shrink tumors and how safe it is. Participants must have measurable disease and be able to follow…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Can better doctor chat improve cancer survivorship?
Knowledge-focused OngoingThis study looks at whether training doctors to communicate better can help lymphoma patients move from active treatment to survivorship. It involves 314 patients with Hodgkin's or Diffuse Large B-cell Lymphoma and their doctors. The goal is to improve how doctors discuss follow-…
Matched conditions: HODGKIN'S LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC